Example searches

DXR Daxor Corp.

Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.

Company profile

Ticker
DXR
Exchange
AMEX
Website
www.daxor.com
CEO
Michael R. Feldschuh
Employees
Incorporated in
New York
Location
New York
Fiscal year end
Dec 31
Sector
Health Technology > Medical Specialties
Industry (SEC)
Surgical & Medical Instruments & Apparatus
3M • Boston Scientific • Baxter International • Stryker • Becton Dickinson & Co • Teleflex • ResMed • Hill-Rom • Integra Lifesciences • AngioDynamics ...
SEC CIK
0000027367
Corporate docs
IRS number
132682108

DXR stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

28 Mar 12
5 Jun 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 11 Sep 11 Dec 10 Sep 10
Revenue 369.83K 340.91K 361.37K 453.28K
Net income -1.49M -4.18M 2.27M 2.6M
Diluted EPS -0.35 -0.99 0.53 0.62
Net profit margin -403% -1227% 627% 575%
Operating income -1.01M -1.26M -1.53M -1.28M
Net change in cash 29.91K -28.03K -49.3K
Cash on hand 59.63K 29.71K 57.74K 107.04K
Cost of revenue 176.95K 149.38K 184.72K 185.74K
Annual (USD) Dec 11 Dec 10
Revenue 1.45M 1.58M
Net income -7.19M 4.97M
Diluted EPS -1.7 1.17
Net profit margin -497% 315%
Operating income -5.79M -5.66M
Net change in cash 1.88K
Cash on hand 59.63K 57.74K
Cost of revenue 652.51K 727.65K

Financial data from Daxor earnings reports

Recent insider trades

DXR insider ownership history Insider history
Date Owner Security Transaction Code $Price #Shares $Value #Remaining
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.2 200 2.44K 154,006
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.4 400 4.96K 153,806
21 Mar 19 Michael Richard Feldschuh Common Stock Buy Aquire P 12.3629 600 7.42K 153,406
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2019

DXR institutional ownership history Ownership history
0.5% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 5 4 +25.0%
Opened positions 1 0 +Infinity%
Closed positions 0 1 -100.0%
Increased positions 0 1 -100.0%
Reduced positions 1 1 –
13F shares
 Current Prev Q Change
Total value 186K 198K -6.1%
Total shares 19.74K 20.51K -3.7%
Total puts 0 0 –
Total calls 0 0 –
Total put/call ratio – – –
Largest owners
 Shares Value Change
Renaissance Technologies 11.1K $104K 0.0%
Prelude Capital Management 7.1K $67K -21.3%
UBS UBS 1.16K $11K NEW
WFC Wells Fargo & Co. 392 $4K 0.0%
Proequities 0 $0
Largest transactions
 Shares Bought/sold Change
Prelude Capital Management 7.1K -1.92K -21.3%
UBS UBS 1.16K +1.16K NEW
WFC Wells Fargo & Co. 392 0 0.0%
Proequities 0 0
Renaissance Technologies 11.1K 0 0.0%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: abdomen, accident, ailure, amputee, andM, Apple, arisen, assigned, bad, bio, byA, calibrated, calibration, capillary, capture, channel, check, chomated, cold, counter, cycle, daily, Database, dehydrated, diffusion, diminished, disruption, eartF, easily, easured, enclosed, EVERESTStudy, exact, external, fabrication, factthat, FAST, filtered, Fukishima, hidden, inH, InHypertension, intake, internationally, inThe, Intuitive, invalid, Jehovah, journalAnesthesia, journalShock, knee, LEU, linearity, Literature, liver, logging, lymphatic, machine, maintenance, mental, Metropolitan, module, muscle, Netflix, nonowner, Notification, notified, ofAnesthesia, ofSEC, ofThe, Operationsfor, Paducah, parallel, petition, pituitary, plant, polar, Portsmouth, quantity, raioisotope, reatment, recycled, remote, retention, Rockville, Roosevelt, Samsca, secretion, shortly, shutdown, Simon, sodium, Solar, spite, ssessment, stable, stemming, substance, suspect, swelling, textbookCritical, theHawaii, toE, Tolvaptan, tourniquet, tsunami, underutilized, urine, warning, wasting, withdrawn, wording
Removed: Abnormal, accidentally, Agranovsky, amounted, automate, Bayside, Burn, contamination, detail, discontinued, dose, Dt, Elena, eligible, elimination, Elmhurst, emphasize, feasible, field, flowing, format, GFR, Glomeril, Hematology, identification, introducing, Manager, Mitchell, needle, owed, progressing, radioactive, receipt, refinancing, Saltzberg, spend, stick, stuck, sum, Taglich, taxed, Unaudited, vice, vital, Wilmington, Wipe
From filing 10-K 2011 FY

Financial reports

View all
10-K
2011 FY
Annual report
28 Mar 12
10-Q
2011 Q3
Quarterly report
14 Nov 11
10-Q/A
2011 Q2
Quarterly report (amended)
31 Aug 11
10-Q
2011 Q2
Quarterly report
9 Aug 11
10-Q
2011 Q1
Quarterly report
13 May 11
10-K
2010 FY
Annual report
29 Mar 11
10-Q
2010 Q3
Quarterly report
12 Nov 10
10-Q
2010 Q2
Quarterly report
13 Aug 10
10-Q
2010 Q1
Quarterly report
11 May 10
10-K
2009 FY
Annual report
29 Mar 10

Current reports

View all
8-K
Other Events
6 May 20
8-K
Other Events
23 Apr 20
8-K
Departure of Directors or Certain Officers
28 Sep 18
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
16 May 17
8-K
Departure of Directors or Certain Officers
16 Feb 17
8-K/A
Departure of Directors or Certain Officers
27 Sep 16
8-K
Departure of Directors or Certain Officers
23 Sep 16
8-K
Departure of Directors or Certain Officers
7 Jul 16
8-K
Departure of Directors or Certain Officers
8 Jul 09
8-K/A
Departure of Directors or Principal Officers
24 Jan 07

Registration and prospectus

POS EX
Additional exhibits for listing
31 Oct 18
RW
Registration withdrawal request
10 May 13
S-8
Registration of securities for employees
6 Jul 04
S-3
Shelf registration
18 Mar 98

Proxies

View all
DEF 14A
Definitive proxy
4 Jun 20
DEFR14A
Revised proxy
3 Jun 19
DEF 14A
Definitive proxy
30 May 19
N-PX/A
Filing
13 Jun 18
DEF 14A
Definitive proxy
22 May 18
DEF 14A
Definitive proxy
14 Nov 17
N-PX/A
Filing
14 Sep 16
DEF 14A
Definitive proxy
19 May 16
DEF 14A
Definitive proxy
18 May 15
DEF 14A
Definitive proxy
12 May 14

Other

View all
EFFECT
Notice of effectiveness
23 May 19
CORRESP
Correspondence with SEC
20 May 19
CORRESP
Correspondence with SEC
17 May 19
CORRESP
Correspondence with SEC
10 May 19
CORRESP
Correspondence with SEC
10 May 19
CORRESP
Correspondence with SEC
3 May 19
CORRESP
Correspondence with SEC
3 Apr 19
EFFECT
Notice of effectiveness
20 Aug 18
CORRESP
Correspondence with SEC
17 Aug 18
CORRESP
Correspondence with SEC
16 Aug 18

Ownership

View all
4
DAXOR / Robert J Michel ownership change
22 Mar 19
4
DAXOR / Michael Richard Feldschuh ownership change
22 Mar 19
4
DAXOR / Robert J Michel ownership change
8 Nov 18
3
DAXOR / Robert J Michel ownership change
8 Nov 18
4
DAXOR / Soren Thompson ownership change
2 Aug 18
4
DAXOR / Edward Feuer ownership change
16 Jul 18
4
DAXOR / Michael Richard Feldschuh ownership change
19 Mar 18
4
DAXOR / Jonathan Adam Feldschuh ownership change
19 Mar 18
4
DAXOR / Soren Thompson ownership change
19 Mar 18
4
DAXOR / JOSEPH FELDSCHUH ownership change
19 Mar 18

Patents

APP
Utility
Flow-through Quantitative Blood Collection Vial
30 Apr 20
A device is presented for storing, transporting, measuring, and collecting blood, having the properties of a precisely determined volume, the ability to be emptied or filled while connected to a continuous source (such as a supply of a drug, or the bloodstream of a patient), and a geometry suitable for the entire device to be placed in the counting chamber of a detector (such as the counting well of a gamma counter).
APP
Utility
Blood Volume Analyzer with Guidance
30 Apr 20
Systems and methods are provided for analyzing blood of a living being, and for presenting guidance for medical treatment.
APP
Utility
Whole Blood Volume Analyzer
30 Apr 20
Systems and methods are provided for measuring blood volume of a living being.